CEFIXIME FOR ORAL SUSPENSION USP 50 MG / 100 MG

CEFUROXIME AXETIL FOR ORAL SUSPENSION USP 125-250 MG/ 5
ML

Indication

For the treatment of the following infections (skin, UTI, ENT) caused by; S. pneumoniae, H. influenzae, staphylococci, S.pyogenes (Group A beta-hemolytic streptococci), E.coli, P.mirabilis, Klebsiella sp, coagulase-negative staphylococci and Streptococcus pyogenes.

pack

30 ML
Category:

Note: Products are not marketed in countries where it is protected by Patent Law